Ixekizumab and Ustekinumab Efficacy in Nail Psoriasis in Patients with Moderate-to-Severe Psoriasis: 52-Week Results from a Phase 3, Head-to-Head Study (IXORA-S)

por Wasel, Norman, Thaçi, Diamant, French, Lars E., Conrad, Curdin, Dutronc, Yves, Gallo, Gaia, Berggren, Lovisa, Lacour, Jean-Philippe
Publicado 2020